Coloplast
Logotype for Coloplast

Coloplast (COLO) investor relations material

Coloplast Investor presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Coloplast
Investor presentation summary6 Feb, 2026

Financial performance and guidance

  • Q1 2025/26 organic revenue grew 6%, with reported growth flat due to currency and divestment impacts; EBIT before special items decreased 3% to DKK 1,850 million, with a margin of 26%.

  • Free cash flow was DKK 1,821 million, with a FCF-to-sales ratio of 26%, supported by lower net financial items.

  • FY 2025/26 guidance remains at around 7% organic growth and 7% EBIT growth in constant currencies, with ROIC expected to improve by 1 percentage point.

  • Reported growth in DKK is expected at 4%, with a 3%-point negative impact from currencies and a small negative impact from the skin care divestment.

  • Tax rate is expected to remain around 22% during the strategic period, benefiting from recent IP transfers.

Business segment performance

  • Ostomy Care grew 4% organically, impacted by negative growth in China and a high baseline in the US; growth expected to pick up later in the year.

  • Continence Care delivered 7% organic growth, led by the Luja™ catheter platform for both male and female users.

  • Voice & Respiratory Care grew 8%, driven by Laryngectomy and broad-based geographic growth.

  • Wound & Tissue Repair grew 5%, with Kerecis delivering 10% organic growth but facing sales disruption from Medicare reimbursement changes.

  • Interventional Urology grew 8%, led by strong US Men's Health performance and recovery in Kidney & Bladder Health.

Strategic priorities and Impact4

  • Impact4 strategy focuses on four pillars: innovative customer offerings, efficiency gains, technology adoption, and cultivating a winning, sustainable company.

  • Ambition for 7-8% organic revenue growth (5-year CAGR) and ROIC above 20% by FY 2029/30.

  • Dynamic resource allocation is fueling high-potential areas such as US Chronic Care, Kerecis, and Intibia commercialization.

  • All business segments are expected to contribute to growth, with Chronic Care as the largest driver.

Kerecis: How will new Medicare pricing impact growth
Impact4: Key drivers for EBIT margin accretion
US Chronic Care: What drives market share gains
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Coloplast earnings date

Logotype for Coloplast
Q1 25/266 Feb, 2026
Coloplast
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Coloplast earnings date

Logotype for Coloplast
Q1 25/266 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Coloplast A/S engages in the development and sale of intimate healthcare products and services. The company offers urology products, such as bladder catheters, external urinary catheter systems, balloon dilators for benign prostatic hyperplasia treatment, stents and grafts, urological drainage bags, and colostomy bags; orthopedic products consisting of sheets with fixation areas, meshes with fixation areas and meshes marketed together with other devices.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage